DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that it will release its 2009 fourth quarter and fiscal year-end results on Monday, March 1, 2010. SuperGen's management team will provide details of the Company's financial results, and provide financial guidance for fiscal year 2010.
